Our study showed that multiple breast cancer parameters including mucinous sub-type of breast cancers, tumor necrosis, PR positivity, ER positivity, mastectomy rates, AND rates, and use of laterazole showed a higher rate among individuals in older age groups. This evidence concerns the gene ESR1 and breast carcinoma.